This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Philip Morris (PM) Strives to Expand IQOS & Beyond Nicotine
by Zacks Equity Research
Philip Morris (PM) is gaining from growing consumer acceptance for IQOS devices. It is on track with the expansion of Beyond Nicotine products to support inhaled therapeutics.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $49.23, moving +1.78% from the previous trading session.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $50.88 in the latest trading session, marking a +0.18% move from the prior day.
Altria (MO) Benefits From Low-Risk Products, High Pricing
by Zacks Equity Research
Altria (MO) is gaining from rising popularity of IQOS and on!. Strong pricing for tobacco products is also driving revenue growth.
Philip Morris (PM) Gains on IQOS, Beyond Nicotine Expansion
by Zacks Equity Research
Philip Morris (PM) is gaining from rising popularity of IQOS devices. The company is also progressing with the expansion of Beyond Nicotine products that cater to medical wellness.
Altria (MO) Hikes Dividend, Boosts Shareholders' Wealth
by Zacks Equity Research
Altria (MO) raises quarterly dividend by 4.7% to 90 cents per share. The company's new annualized dividend rate is $3.60 per share.
Philip Morris (PM) Fuels Smoke-Free Offerings With IQOS ILUMA
by Zacks Equity Research
Philip Morris International (PM) unveils the launch of IQOS ILUMA. These bladeless devices generate no smoke and combustion, and will strengthen the company's smoke-free portfolio.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Top Research Reports for Costco, Altria & Edwards Lifesciences
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale (COST), Altria Group, Inc. (MO), and Edwards Lifesciences (EW).
Company News for Jul 30, 2021
by Zacks Equity Research
Companies In The News Are: NOK, YUM, MA, MO.
Altria (MO) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Altria's (MO) second-quarter performance reflects gains from growth in revenues across all categories, backed by favorable pricing variance and shipment volumes.
Altria (MO) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 5.13% and 4.71%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Altria (MO) Lined Up for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Altria's (MO) second-quarter 2021 results are likely to reflect solid pricing power and strength in oral tobacco products.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.49, moving +1.06% from the previous trading session.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $46.99, marking a -0.72% move from the previous day.
Altria (MO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Stock Moves -0.46%: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.27, moving -0.46% from the previous trading session.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $47.49, moving +0.19% from the previous trading session.
Altria (MO) to Divest Ste. Michelle Wine Estates Business
by Zacks Equity Research
Altria's (MO) subsidiary agrees to sell Ste. Michelle Wine Estates business. The move will boost shareholders' value, while aiding in smooth transition of adult smokers to a non-combustible future.
Company News for Jul 12, 2021
by Zacks Equity Research
Companies In The News Are: LEVI, PM, UAL, MO
Altria (MO) Up 14% in 6 Months, Gains on Low-Risk Products
by Zacks Equity Research
Altria's (MO) low-risk tobacco offerings such as IQOS and on! are gaining popularity. Moreover, strong pricing for tobacco products is an upside.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $47.53 in the latest trading session, marking a -0.63% move from the prior day.
Top Stock Reports for Pfizer, Qualcomm & Philip Morris
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), QUALCOMM (QCOM), and Philip Morris International (PM).
Philip Morris (PM) Up 10% in 3 Months, Gains on Pricing & RRPs
by Zacks Equity Research
Philip Morris (PM) is gaining from rising popularity of IQOS devices. Additionally, pricing power, especially for combustible products, is an upside.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $46.78, moving -0.85% from the previous trading session.